If you're in midlife, your risk may be changing-even if your numbers aren't.

Adults with a history of or at risk for a first atherosclerotic cardiovascular disease (ASCVD) event who received the oral proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor enlicitide ...

The pill, named enlicitide, operates by helping the body eliminate cholesterol, a mechanism currently only achievable through ...

Please provide your email address to receive an email when new articles are posted on . An oral PCSK9 inhibitor lowered LDL cholesterol by up to 60% and improved other lipid parameters at 24 weeks.

For years, the public was taught to fear any food containing dietary cholesterol, leading many to avoid nutrient-dense options like eggs and shellfish. However, the latest research has finally drawn a ...